StockData
Dogwood Therapeutics, Inc. logo

Dogwood Therapeutics, Inc. (DWTX) stock

DWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.08+0.00 (0.00%)

Close on Nov 18, 2026Market cap $36.71MP/E –Yield –

Dogwood Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Dogwood Therapeutics's enterprise value was $30.07M on Nov 11, 2026, against $4.82M a year earlier. Over the last 5 years it ranged from -$8.47M to $344.66M, with a median of $6.17M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$30.07M–
2025Dec 31, 2025-$587.16K-100.9%
2024Dec 31, 2024$67.08M+966.9%
2023Dec 29, 2023$6.29M–
2022Dec 30, 2022-$5.46M-123.3%
2021Dec 31, 2021$23.42M–

More Dogwood Therapeutics figures

See a number that looks wrong?